- Published on
Toxicology – Synthetic Drugs and “Research Chemicals”
Overview
Synthetic drugs emerged as a major public health concern around 2008, particularly in the United States and Europe. Many of these substances are manufactured abroad and imported in bulk as so-called “research chemicals,” often labeled “not for human consumption” to bypass regulatory scrutiny. Once distributed, they are repackaged and marketed based on their intended psychoactive effects.
How They Are Marketed
After importation, these compounds are disguised as legitimate products. Synthetic cannabinoids are sprayed onto plant material and sold as “herbal incense,” while stimulant-type drugs such as substituted cathinones are marketed as “bath salts,” “plant food,” or similar items. Their labeling and non-tablet form initially allowed them to evade regulation.
Common Categories and Examples
Synthetic Stimulants (“Bath Salts”)
These include substituted cathinones such as MDPV, mephedrone, and methylone, which produce effects similar to cocaine or amphetamines.
Synthetic Cannabinoids (“Spice,” “K2”)
These compounds act on cannabinoid receptors and include agents such as JWH-018, JWH-073, CP-47,497, HU-210, and AM-2201.
Hallucinogens
Compounds like Bromo-DragonFLY and 2C-I (“Smiles”) are potent serotonergic hallucinogens with effects similar to LSD.
Stimulant Analogs
Substances such as ethylphenidate (sometimes marketed as “glass cleaner”) resemble prescription stimulants like methylphenidate.
Sedative Analogs
Products sold as “herbal Xanax” may contain compounds like phenazepam, a long-acting benzodiazepine analog.
Opioid-Like and Mixed Products
Some substances, such as “Krypton,” combine kratom with opioid-like compounds (e.g., O-desmethyltramadol), increasing toxicity risk.
Other Street Names
Key Points
107
Overview
Synthetic drugs emerged as a major public health concern around 2008, particularly in the United States and Europe. Many of these substances are manufactured abroad and imported in bulk as so-called “research chemicals,” often labeled “not for human consumption” to bypass regulatory scrutiny. Once distributed, they are repackaged and marketed based on their intended psychoactive effects.
How They Are Marketed
After importation, these compounds are disguised as legitimate products. Synthetic cannabinoids are sprayed onto plant material and sold as “herbal incense,” while stimulant-type drugs such as substituted cathinones are marketed as “bath salts,” “plant food,” or similar items. Their labeling and non-tablet form initially allowed them to evade regulation.
Common Categories and Examples
Synthetic Stimulants (“Bath Salts”)
These include substituted cathinones such as MDPV, mephedrone, and methylone, which produce effects similar to cocaine or amphetamines.
Synthetic Cannabinoids (“Spice,” “K2”)
These compounds act on cannabinoid receptors and include agents such as JWH-018, JWH-073, CP-47,497, HU-210, and AM-2201.
Hallucinogens
Compounds like Bromo-DragonFLY and 2C-I (“Smiles”) are potent serotonergic hallucinogens with effects similar to LSD.
Stimulant Analogs
Substances such as ethylphenidate (sometimes marketed as “glass cleaner”) resemble prescription stimulants like methylphenidate.
Sedative Analogs
Products sold as “herbal Xanax” may contain compounds like phenazepam, a long-acting benzodiazepine analog.
Opioid-Like and Mixed Products
Some substances, such as “Krypton,” combine kratom with opioid-like compounds (e.g., O-desmethyltramadol), increasing toxicity risk.
Other Street Names
- “Molly”: Marketed as pure MDMA but often contains synthetic cathinones
- “Meow-meow”: Another name for mephedrone
- “Plant food”: Often used to disguise stimulant cathinones
Key Points
- Synthetic drugs are chemically diverse and often unpredictable in potency and effects.
- They are frequently mislabeled, making identification and management challenging.
- Many are not detected on routine drug screening tests.
107
0 Comments
